(BOSULIF is registered trademarks PFIZER)
Bosulif – Bosutinib 100 mg and 500 mg is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine, and Innovator samples, etc.
What is BOSULIF:
BOSULIF is a medicine that contains the active substance Bosutinib and is available as tablets.
In how many countries BOSULIF is approved for marketing?
BOSULIF is available/approved in USA and Europe. We can help you to access it in India.
What is BOSULIF used for?
BOSULIF is indicated for the treatment of adult patients with chronic, accelerated, or blast phase Ph+ chronic myelogenous leukemia (CML) with resistance or intolerance to prior therapy.
How can I get BOSULIF in India?
BOSULIF is a prescription only drug and is not approved for marketing in India.
The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.
Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at – email@example.com
We facilitate by-
- Helping in documentation to import the medicine for personal use
- Finding Genuine and reliable source in USA, Europe and Japan
- Ensuring 100% transparency.
BOSULIF can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.
The Indian Pharma can facilitate the supply of BOSULIF (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.
The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees